Pfizer’s Litfulo significantly improved skin pigment measures in two pivotal studies in vitiligo, results that were presented during European Academy of Dermatology and Venereology annual meeting. If Pfizer’s daily pill is approved, it would compete against an Incyte topical cream that is currently the only FDA-approved therapy for this autoimmune skin disorder. The post Pfizer…
Data, behavioral insights, and experimentation can be used to understand how stress, motivation, and trust shape company culture. Positively changing company culture leads to direct improvements in patient health outcomes, clinician wellbeing, and company performance. The post It’s Time We Reframe Healthcare Organizational Culture Using Behavioral Science appeared first on MedCity News.
[Sponsored] In this webinar pharmacy leaders share how hospitals are using stewardship as a sustainability strategy to control costs and ease the load on pharmacists. The post Hospitals’ Cost Containment Conundrum appeared first on MedCity News.
The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024. The post AMA: PBM Market Concentration Is On the Rise appeared first on MedCity News.
Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages over Dupixent, the blockbuster immunology drug spawned by their R&D alliance. The companies project these drugs will start reaching pivotal testing in 2029 — important because Dupixent faces patent expiration in 2031. The post Sanofi Puts Up $1B to Expand…
Why more than 300,000 missing patient records reveal an engineering problem, not a policy one — and why that’s good news. The post The Real Gap in All of Us Isn’t Consent, It’s Conversion appeared first on MedCity News.
The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have met less frequently during the Trump administration, more meetings have been scheduled since former Commissioner Marty Makary left the agency in May. The post FDA Looks to Bring New Scientific, Consumer Voices to Advisory Committees appeared…
In this episode, we’re joined by Claire Love, PwC’s global health industries advisory leader. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market. The post MedCity FemFwd: Opportunities in the Fertility Market appeared first on MedCity News.
Health tech companies made several major funding announcements in September. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in September appeared first on MedCity News.
For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving human decision-making behind. It’s healthcare organizations harnessing AI primarily to increase efficiency while leaving healthcare providers even more mired in complexity and regulation. The post AI’s Healthcare ‘Doomsday’? It May Be Less About Autonomy Than…